These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23580180)

  • 1. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
    Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
    Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
    Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
    Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.
    Jayasinghe C; Simiantonaki N; Michel-Schmidt R; Kirkpatrick CJ
    Oncol Rep; 2009 Nov; 22(5):1093-100. PubMed ID: 19787226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.
    D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
    Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
    Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
    Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer.
    Kluftinger AM; Robinson BW; Quenville NF; Finley RJ; Davis NL
    Surg Oncol; 1992 Feb; 1(1):97-105. PubMed ID: 1285215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of lymphangiogenesis to progression of colorectal cancer].
    Wang TB; Huang YH; Lan P; Song XM; Wang JP
    Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.
    Tremmel M; Matzke A; Albrecht I; Laib AM; Olaku V; Ballmer-Hofer K; Christofori G; Héroult M; Augustin HG; Ponta H; Orian-Rousseau V
    Blood; 2009 Dec; 114(25):5236-44. PubMed ID: 19773544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
    Zhang XM; Han WX; Wang HY; He Q
    World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
    Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.